CHINOOK THERAPEUTICS CVR
CUSIP 169CVR016
Chinook Therapeutics Cvr has 2 institutional holders in Filings Flow’s 13F database, together reporting 87.2K shares worth $0 as of Q1 2026. The largest reported holders are Propel Bio Management, LLC, Rhumbline Advisers, and Sterling Capital Management LLC.
Institutional Holders
2
Q1 2026
Reported Value
$0
Ticker
unmapped
private placement or foreign
Quarters Tracked
2
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| Propel Bio Management, LLC$159M AUM | 0.00% | $2,500 | 79.4K | Q2 2025OLDER |
| RHUMBLINE ADVISERS$116.9B AUM | — | $0 | 87.2K | Q1 2026 |
| Sterling Capital Management LLC$5.3B AUM | — | $0 | 1.0K | Q2 2025OLDER |
| Kohmann Bosshard Financial Services, LLC$1.0B AUM | — | $0 | 5 | Q4 2025OLDER |
| Ascentis Independent Advisors$1.3B AUM | — | $0 | 30 | Q1 2026 |
| ORG Partners LLC$568M AUM | — | $0 | 30 | Q3 2025OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.